Is there a future for other glutamate receptor modulators in the pharmacotherapy of mood disorders?

被引：0
|
作者：
Sos, Peter [1 ]
机构：
[1] Natl Inst Mental Hlth, Klecany, Czech Republic
来源：
EVIDENCE-BASED MENTAL HEALTH | 2016年 / 19卷 / 03期
关键词：
D O I：
10.1136/eb-2015-102261
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
引用
收藏
页码：95 / 96
页数：2
相关论文
共 50 条
  • [31] Pharmacotherapy of comorbid mood, anxiety, and substance use disorders
    Brady, KT
    Verduin, ML
    SUBSTANCE USE & MISUSE, 2005, 40 (13-14) : 2021 - 2041
  • [32] CONTINUATION AND MAINTENANCE PHARMACOTHERAPY FOR UNIPOLAR AND BIPOLAR MOOD DISORDERS
    SOLOMON, DA
    BAUER, MS
    PSYCHIATRIC CLINICS OF NORTH AMERICA, 1993, 16 (03) : 515 - 540
  • [33] Investigation of glutamate receptor subunit genes and childhood-onset mood disorders (COMD)
    Dorval, KM
    Burcescu, I
    Adams, J
    Wigg, K
    King, N
    Vetró, A
    Kiss, E
    Kapornai, K
    Gádoros, J
    Kennedy, JL
    Kovacs, M
    Barr, CL
    BIOLOGICAL PSYCHIATRY, 2006, 59 (08) : 215S - 215S
  • [34] FUTURE TREATMENT OF MOOD DISORDERS
    Young, A.
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY, 2024, 58 : 4 - 4
  • [35] Future directions in the pharmacotherapy of anxiety disorders
    Stein, D. J.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2006, 9 : S10 - S10
  • [36] GABA-glutamate interactions and mood disorders
    Sanacora, G
    BIOLOGICAL PSYCHIATRY, 2001, 49 (08) : 149S - 149S
  • [37] Glutamate related signal transduction in mood disorders
    Ozawa, H
    Ikeda, H
    Nakano, N
    Saito, T
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2002, 17 : S107 - S107
  • [38] Mood disorders: Regulation by metabotropic glutamate receptors
    Pilc, Andrzej
    Chaki, Shigeyuki
    Nowak, Gabriel
    Witkin, Jeffrey M.
    BIOCHEMICAL PHARMACOLOGY, 2008, 75 (05) : 997 - 1006
  • [39] Pharmacology of Metabotropic Glutamate Receptor Allosteric Modulators: Structural Basis and Therapeutic Potential for CNS Disorders
    Gregory, Karen J.
    Noetzel, Meredith J.
    Niswender, Colleen M.
    OLIGOMERIZATION AND ALLOSTERIC MODULATION IN G-PROTEIN COUPLED RECEPTORS, 2013, 115 : 61 - 121
  • [40] Allosteric modulators of metapotropic glutamate receptor subtype 5 as a novel approach for treatment of CNS disorders
    Conn, P. J.
    Rodriguez, A. L.
    Ayala, J. E.
    Jones, C. K.
    Barrett, R.
    Niswender, C. M.
    Weaver, C. D.
    Jadhav, S.
    Sheffler, D. J.
    Hammond, A. S.
    Williams, R.
    Sharma, S.
    Lindsley, C. W.
    NEUROPHARMACOLOGY, 2008, 55 (04) : 593 - 593
12345